PROCEEDINGS VOLUME 2924
BIOS EUROPE '96 | 7-10 SEPTEMBER 1996
Photochemotherapy: Photodynamic Therapy and Other Modalities II
IN THIS VOLUME

0 Sessions, 44 Papers, 0 Presentations
Basic Studies  (13)
BIOS EUROPE '96
7-10 September 1996
Vienna, Austria
Basic Studies
Proc. SPIE 2924, How many molecules of a photosensitizer are necessary to photosensitize a tumor cell?, 0000 (4 December 1996); doi: 10.1117/12.260749
Proc. SPIE 2924, Measurement and modelling of protoporphyrin IX photo-oxidation during superficial PDT, 0000 (4 December 1996); doi: 10.1117/12.260767
Proc. SPIE 2924, Energetics of chlorins as potent photosensitizers of PDT, 0000 (4 December 1996); doi: 10.1117/12.260783
Proc. SPIE 2924, Control of photosensitizer in tissue during photodynamic therapy by means of absorption spectroscopy, 0000 (4 December 1996); doi: 10.1117/12.260790
Preclinical Studies I
Proc. SPIE 2924, Specific labeling of microtumors in the hen's egg test system by dimethoxyhematoporphyrin, 0000 (4 December 1996); doi: 10.1117/12.260791
Proc. SPIE 2924, Comparison of the photoactivation efficacy of two chlorin derivatives, 0000 (4 December 1996); doi: 10.1117/12.260792
Proc. SPIE 2924, Cyclic accumulation strategies for polyphasic photoimmunotherapy using the biotin-avidin system, 0000 (4 December 1996); doi: 10.1117/12.260750
Proc. SPIE 2924, In vitro phototoxicity of a new phthalocyanine-immunoconjugate for use in photodynamic therapy, 0000 (4 December 1996); doi: 10.1117/12.260752
Proc. SPIE 2924, Fine structure of carcinosarcoma cells and peritoneal macrophages activated by photodynamic therapy during their interaction in vivo, 0000 (4 December 1996); doi: 10.1117/12.260753
Preclinical Studies II
Proc. SPIE 2924, In vivo uptake and biodistribution of lipophilic and hydrophilic photosensitizers, 0000 (4 December 1996); doi: 10.1117/12.260754
Proc. SPIE 2924, In vivo photodynamic therapy with meso-tetra(m-hydroxyphenyl)chlorin (mTHPC): influence of light intensity and optimization of photodynamic efficiency, 0000 (4 December 1996); doi: 10.1117/12.260755
Proc. SPIE 2924, Flow cytometric studies of cellular uptake of PII, m-THPP and m-THPC: kinetics and cell density dependence, 0000 (4 December 1996); doi: 10.1117/12.260756
Proc. SPIE 2924, Photodynamic treatment with zinc poly-substituted phthalocyanines causes the release of tissue factor in an endothelial cell line, 0000 (4 December 1996); doi: 10.1117/12.260757
Proc. SPIE 2924, Interaction of photosensitizers with membranes of liposomes and of erythrocytes, 0000 (4 December 1996); doi: 10.1117/12.260758
Clinical Studies
Proc. SPIE 2924, Development of photodynamic therapy for Barrett's esophagus, 0000 (4 December 1996); doi: 10.1117/12.260759
Proc. SPIE 2924, Photodynamic therapy of recurrent cancer of oral cavity: an alternative to conventional treatment, 0000 (4 December 1996); doi: 10.1117/12.260760
Proc. SPIE 2924, Four-year clinical experience in photodynamic therapy, 0000 (4 December 1996); doi: 10.1117/12.260761
Proc. SPIE 2924, Intraoperative photodynamic therapy in laryngeal part of pharynx cancers, 0000 (4 December 1996); doi: 10.1117/12.260762
Basic Studies
Proc. SPIE 2924, Experimental PDT: studies on new Si-phthalocyanines and Si-naphthalocyanines in Cremophor emulsions, 0000 (4 December 1996); doi: 10.1117/12.260764
Preclinical Studies II
Proc. SPIE 2924, Ozone-photodynamic effect in the experiment in vitro, 0000 (4 December 1996); doi: 10.1117/12.260765
Proc. SPIE 2924, Possibility of deep photodynamic action on tumor tissues using aluminium phtalocyanine, 0000 (4 December 1996); doi: 10.1117/12.260766
Basic Studies
Proc. SPIE 2924, Photodynamic activity of a number of photosensitizers in vitro, 0000 (4 December 1996); doi: 10.1117/12.260768
Proc. SPIE 2924, Photosensitizer for PDT based on phosphonate phthalocyanine derivative, 0000 (4 December 1996); doi: 10.1117/12.260769
Proc. SPIE 2924, Spectroscopic studies of photosensitizer-human serum albumin complexes and their photostability, 0000 (4 December 1996); doi: 10.1117/12.260770
Clinical Studies
Proc. SPIE 2924, Multi-course PDT of malignant tumors: the influence on primary tumor, metastatic spreading and homeostasis of cancer patients, 0000 (4 December 1996); doi: 10.1117/12.260771
Preclinical Studies II
Proc. SPIE 2924, Pharmocokinetical study of Al- and Zn-sulphonated phthalocyanines, 0000 (4 December 1996); doi: 10.1117/12.260772
Proc. SPIE 2924, Aggregation and hemolysis of human erythrocytes at photodynamic therapy, 0000 (4 December 1996); doi: 10.1117/12.260773
Basic Studies
Proc. SPIE 2924, Novel effective sensitizers for photodynamic cancer therapy on the base of chlorin p6 and its derivatives, 0000 (4 December 1996); doi: 10.1117/12.260774
Preclinical Studies II
Proc. SPIE 2924, Combined treatment of photodynamic therapy and the topoisomerase I inhibitor camptothecin in growing V79 and NHIK 3025 cells, 0000 (4 December 1996); doi: 10.1117/12.260775
Proc. SPIE 2924, Enhancement of photosensitization efficiency by various combinations with radiosensitization in an experimental Ehrlich ascites tumor, 0000 (4 December 1996); doi: 10.1117/12.260776
Proc. SPIE 2924, Quantitative analysis of anthracyclines kinetics in cells varying in drug responsiveness, 0000 (4 December 1996); doi: 10.1117/12.260777
Proc. SPIE 2924, Laser-induced fluorescence spectroscopy of AlPc4 and liposomal ZnPc in a rat bladder tumor model and correlation with PDT efficiency, 0000 (4 December 1996); doi: 10.1117/12.260778
Proc. SPIE 2924, Comparison of meso-tetrahydroxyphenyl-chlorin and meso-tetrahydroxyphenyl-bacteriochlorin with respect to photobleaching and PCT efficiency in vivo, 0000 (4 December 1996); doi: 10.1117/12.260779
Basic Studies
Proc. SPIE 2924, Kinetic studies of porphyrin distribution in suspensions of tumor cells, 0000 (4 December 1996); doi: 10.1117/12.260780
Preclinical Studies II
Proc. SPIE 2924, Bioelectric response of single neuron to photodynamic action of chlorin e6, 0000 (4 December 1996); doi: 10.1117/12.260781
Basic Studies
Proc. SPIE 2924, Intravesical dosimetry applied to laser positioning in photodynamic therapy, 0000 (4 December 1996); doi: 10.1117/12.260782
Proc. SPIE 2924, Laser fluorescence investigation of chlorin e6 pharmacokinetics, 0000 (4 December 1996); doi: 10.1117/12.260784
Clinical Studies
Proc. SPIE 2924, Establishment of treatment parameters for ALA-PDT of plaque psoriasis, 0000 (4 December 1996); doi: 10.1117/12.260785
Proc. SPIE 2924, Photodynamic therapy in patients with advanced breast cancer: preliminary results, 0000 (4 December 1996); doi: 10.1117/12.260786
Basic Studies
Proc. SPIE 2924, Kinetics of self-sensitized oxidation of dye for photodynamic therapy and of sensitized protein oxidation in aqueous solutions, 0000 (4 December 1996); doi: 10.1117/12.260787
Clinical Studies
Proc. SPIE 2924, How to determine an appropriate dose when using various light sources in photodynamic therapy, 0000 (4 December 1996); doi: 10.1117/12.260788
Preclinical Studies II
Proc. SPIE 2924, Nd: YAG laser destruction together with PDT in head and neck, 0000 (4 December 1996); doi: 10.1117/12.260789
Plenary Paper
Proc. SPIE 2924, Colorful story of phototherapy for neonatal jaundice, 0000 (4 December 1996); doi: 10.1117/12.260751
Back to Top